Your browser doesn't support javascript.
Determinants of Hospitalization Costs among Moderate Cases of COVID-19.
Li, BinBin; Chen, LaiTe; Shi, Lu.
  • Li B; Yongjia County People's Hospital, China.
  • Chen L; Sir Run Run Shaw Hospital, 56660Zhejiang University School of Medicine, China.
  • Shi L; Department of Public Health Sciences, 2545Clemson University, Clemson, SC, USA.
Inquiry ; 59: 469580211059483, 2022.
Article in English | MEDLINE | ID: covidwho-1731416
ABSTRACT

Objective:

To estimate demographic predictors of medical expense in hospitalization of moderate COVID-19.

Methods:

From January to March 2020, a total of 39 patients were treated and recovered from COVID-19 in a tertiary medical center in East China. Detailed cost data were collected and we estimated the demographic predictors of both total hospital expense and daily hospital expense.

Results:

The mean medical expense for treating hospitalized moderate COVID-19 cases was $1177.81. Every additional year in the patient's age corresponds to .9% more in total hospital expense (Coef. = 0.009, 95% CI 0.002-0.017, P < 0.01). The difference in daily medical expense between age groups was not statistically significant.

Conclusions:

Hospitalization cost was significantly elevated among the older patients, and the age effect in cost was mainly driven by the longer length of stay in the hospital. From a cost-saving perspective, the elderly population might deserve priority consideration when COVID-19 vaccination programs are implemented.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Aged / Humans Language: English Journal: Inquiry Year: 2022 Document Type: Article Affiliation country: 00469580211059483

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Aged / Humans Language: English Journal: Inquiry Year: 2022 Document Type: Article Affiliation country: 00469580211059483